Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 08:43:13 UTC |
---|
Update Date | 2021-09-26 23:03:20 UTC |
---|
HMDB ID | HMDB0251365 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Dilmapimod |
---|
Description | Dilmapimod belongs to the class of organic compounds known as phenylpyrimidines. These are polycyclic aromatic compounds containing a benzene ring linked to a pyrimidine ring through a CC or CN bond. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions. Dilmapimod is a moderately basic compound (based on its pKa). Dilmapimod (SB-681323) is a p38 MAP-kinase inhibitor that has potential uses in inflammatory conditions such as RA (Rheumatoid Arthritis). In diseases such as RA and IBD, TNFα blockade through either anti-TNFα antibodies or use of soluble TNFα receptors. Methotrexate (common treatment for RA patients) also has potential liver toxicity. Inhibition of p38α offers significant inhibition of TNFα, and cytokines such as IL-1β and IL-6, which offer additional therapeutic efficacy. Previous p38 MAP-kinase inhibitors have been hindered in development by liver toxicity. Dilmapimod reduces the levels of proinflammatory cytokines and chemokines and reduce cellular infiltration to sites of inflammation, thereby reducing local damage. Dilmapimod has been used in trials studying the treatment and diagnostic of Nerve Trauma, Inflammation, Pain, Neuropathic, Arthritis, Rheumatoid, and Coronary Heart Disease, among others. This compound has been identified in human blood as reported by (PMID: 31557052 ). Dilmapimod is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Dilmapimod is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CC1=CC(F)=CC=C1C1=C2C=CC(=O)N(C2=NC(NC(CO)CO)=N1)C1=C(F)C=CC=C1F InChI=1S/C23H19F3N4O3/c1-12-9-13(24)5-6-15(12)20-16-7-8-19(33)30(21-17(25)3-2-4-18(21)26)22(16)29-23(28-20)27-14(10-31)11-32/h2-9,14,31-32H,10-11H2,1H3,(H,27,28,29) |
---|
Synonyms | Not Available |
---|
Chemical Formula | C23H19F3N4O3 |
---|
Average Molecular Weight | 456.425 |
---|
Monoisotopic Molecular Weight | 456.140924977 |
---|
IUPAC Name | 8-(2,6-difluorophenyl)-2-[(1,3-dihydroxypropan-2-yl)amino]-4-(4-fluoro-2-methylphenyl)-7H,8H-pyrido[2,3-d]pyrimidin-7-one |
---|
Traditional Name | 8-(2,6-difluorophenyl)-2-[(1,3-dihydroxypropan-2-yl)amino]-4-(4-fluoro-2-methylphenyl)pyrido[2,3-d]pyrimidin-7-one |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC1=CC(F)=CC=C1C1=C2C=CC(=O)N(C2=NC(NC(CO)CO)=N1)C1=C(F)C=CC=C1F |
---|
InChI Identifier | InChI=1S/C23H19F3N4O3/c1-12-9-13(24)5-6-15(12)20-16-7-8-19(33)30(21-17(25)3-2-4-18(21)26)22(16)29-23(28-20)27-14(10-31)11-32/h2-9,14,31-32H,10-11H2,1H3,(H,27,28,29) |
---|
InChI Key | ORVNHOYNEHYKJG-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenylpyrimidines. These are polycyclic aromatic compounds containing a benzene ring linked to a pyrimidine ring through a CC or CN bond. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Diazines |
---|
Sub Class | Pyrimidines and pyrimidine derivatives |
---|
Direct Parent | Phenylpyrimidines |
---|
Alternative Parents | |
---|
Substituents | - 4-phenylpyrimidine
- Pyridopyrimidine
- Pyrido[2,3-d]pyrimidine
- Aminopyrimidine
- Fluorobenzene
- Halobenzene
- Pyridinone
- Toluene
- Aryl fluoride
- Pyridine
- Benzenoid
- Aryl halide
- Monocyclic benzene moiety
- Heteroaromatic compound
- Lactam
- Azacycle
- Organic oxide
- Organofluoride
- Organohalogen compound
- Organonitrogen compound
- Alcohol
- Amine
- Organooxygen compound
- Organic nitrogen compound
- Primary alcohol
- Organic oxygen compound
- Hydrocarbon derivative
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Dilmapimod,3TMS,isomer #1 | CC1=CC(F)=CC=C1C1=NC(N(C(CO[Si](C)(C)C)CO[Si](C)(C)C)[Si](C)(C)C)=NC2=C1C=CC(=O)N2C1=C(F)C=CC=C1F | 3379.1 | Semi standard non polar | 33892256 | Dilmapimod,3TMS,isomer #1 | CC1=CC(F)=CC=C1C1=NC(N(C(CO[Si](C)(C)C)CO[Si](C)(C)C)[Si](C)(C)C)=NC2=C1C=CC(=O)N2C1=C(F)C=CC=C1F | 3359.3 | Standard non polar | 33892256 | Dilmapimod,3TMS,isomer #1 | CC1=CC(F)=CC=C1C1=NC(N(C(CO[Si](C)(C)C)CO[Si](C)(C)C)[Si](C)(C)C)=NC2=C1C=CC(=O)N2C1=C(F)C=CC=C1F | 4012.6 | Standard polar | 33892256 | Dilmapimod,3TBDMS,isomer #1 | CC1=CC(F)=CC=C1C1=NC(N(C(CO[Si](C)(C)C(C)(C)C)CO[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=C1C=CC(=O)N2C1=C(F)C=CC=C1F | 3854.2 | Semi standard non polar | 33892256 | Dilmapimod,3TBDMS,isomer #1 | CC1=CC(F)=CC=C1C1=NC(N(C(CO[Si](C)(C)C(C)(C)C)CO[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=C1C=CC(=O)N2C1=C(F)C=CC=C1F | 3830.9 | Standard non polar | 33892256 | Dilmapimod,3TBDMS,isomer #1 | CC1=CC(F)=CC=C1C1=NC(N(C(CO[Si](C)(C)C(C)(C)C)CO[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=C1C=CC(=O)N2C1=C(F)C=CC=C1F | 4175.2 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Dilmapimod GC-MS (Non-derivatized) - 70eV, Positive | splash10-004l-0009600000-6276e99663835a65a602 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Dilmapimod GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Dilmapimod GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Dilmapimod GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Dilmapimod GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Dilmapimod GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Dilmapimod GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Dilmapimod GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Dilmapimod GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Dilmapimod GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dilmapimod 10V, Positive-QTOF | splash10-0a4r-0000900000-ba9bf0e45cf3ef93e92c | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dilmapimod 20V, Positive-QTOF | splash10-052r-1002900000-63d5c9768367aac299b4 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dilmapimod 40V, Positive-QTOF | splash10-02u0-1109000000-ff7d6fbd142d85400a18 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dilmapimod 10V, Negative-QTOF | splash10-0a4i-0001900000-5ecd1115901b497305fc | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dilmapimod 20V, Negative-QTOF | splash10-0a4r-0003900000-8e7bf629c0263be46699 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dilmapimod 40V, Negative-QTOF | splash10-001i-5019200000-871d0694b7ba54886431 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dilmapimod 10V, Positive-QTOF | splash10-0a4i-0000900000-f053a7fe956f4d9688cb | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dilmapimod 20V, Positive-QTOF | splash10-0a4i-0000900000-16a6bec4de4d0ab61569 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dilmapimod 40V, Positive-QTOF | splash10-01q9-0009200000-1a175478271fbabf0edd | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dilmapimod 10V, Negative-QTOF | splash10-0a4i-0000900000-5432408319cd0de11251 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dilmapimod 20V, Negative-QTOF | splash10-001i-0009500000-43ffa8018323dc1c91b5 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dilmapimod 40V, Negative-QTOF | splash10-0pb9-0049500000-b1b627f459c202b9baaf | 2021-10-12 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | Not Available |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected but not Quantified | Not Quantified | Not Specified | Not Specified | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB12140 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | Not Available |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 10297982 |
---|
PDB ID | Not Available |
---|
ChEBI ID | Not Available |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]
|
---|